Evogen | GenomeWeb


NEW YORK (GenomeWeb News) – MRIGlobal and Evogen today announced a five-year agreement to develop molecular diagnostic products targeting the in vitro and clinical molecular diagnostic markets.

Evogen, a Lenexa, Kansas-based developer of molecular detection and diagnostic technologies, said this week that it has non-exclusively licensed its PCR probe technology to Focus Diagnostics, a Quest Diagnostics subsidiary.

NEW YORK (GenomeWeb News) – Evogen has granted Focus Diagnostics a license to incorporate Evogen's HyBeacons PCR probe technology into Focus' molecular diagnostic products and services, the firms announced today.

Lumora has appointed Jim Reid as chairman.

Cepheid said this week that its board of directors has elected John Bishop as chairman and Cristina Kepner as lead independent director.

People in the News

Mari Baker is leaving Navigenics, Andrew von Eschenbach has joined a consulting firm, Jay Flatley takes a seat on Helixis' board, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.